Wilbanks Smith & Thomas Asset Management LLC Novartis Ag Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $434,602 - $481,481	-5,291 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$80.93 - $91.1 $21,851 - $24,597	270 Added 5.38%	5,291 $462,000
Q1 2020 May 06, 2020	SELL	$70.67 - $99.01 $68,761 - $96,336	-973 Reduced 16.23%	5,021 $414,000
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $33,571 - $37,957	398 Added 7.11%	5,994 $568,000
Q3 2019 Nov 06, 2019	SELL	$85.54 - $94.26 $72,024 - $79,366	-842 Reduced 13.08%	5,596 $486,000
Q2 2019 Aug 07, 2019	SELL	$75.4 - $92.8 $12,365 - $15,219	-164 Reduced 2.48%	6,438 $588,000
Q1 2019 May 13, 2019	BUY	$75.32 - $86.15 $31,860 - $36,441	423 Added 6.85%	6,602 $0
Q4 2018 Feb 08, 2019	SELL	$73.66 - $82.02 $88,760 - $98,834	-1,205 Reduced 16.32%	6,179 $530,000
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $79,859 - $92,373	1,193 Added 19.27%	7,384 $636,000
Q2 2018 Aug 08, 2018	SELL	$64.91 - $73.36 $2,726 - $3,081	-42 Reduced 0.67%	6,191 $468,000
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $2,182 - $2,608	-31 Reduced 0.49%	6,233 $504,000
Q4 2017 Feb 07, 2018	SELL	$72.33 - $77.64 $10,849 - $11,646	-150 Reduced 2.34%	6,264 $526,000
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $10,453 - $10,895	141 Added 2.25%	6,414 $551,000
Q2 2017 Aug 15, 2017	BUY	N/A	6,273	6,273 $524,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account